Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC
收藏数据链接：
官方服务：
资源简介：
Information of ATCC cell lines
创建时间：
2023-01-04
